FFP 15–20 ml/kg given 8–12 hourly may be used as first line therapy to treat acquired neonatal purpura fulminans in association with protein C or protein S deficiency while the underlying cause is being investigated. The gene discussed is PROS1; the disease is hyperinsulinemic hypoglycemia, familial, 4.